“INTERPHEX 2016 was a resounding success for both exhibitors and attendees alike who hailed from 52 countries around the world and 48 states across the U.S.,” said Ed Several, Senior Vice President, INTERPHEX.
New York, NY (PRWEB) May 05, 2016
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, sponsored by the Parenteral Drug Association (PDA), today announced an +18% increase in Pharmaceutical Engineers and a +4.5% increase in total attendance for its 2016 event. Attendees and exhibitors from 48 states and 52 countries joined together at INTERPHEX 2016 to experience the latest in technology, and leading edge education. An exhibit hall featuring more than 600 leading suppliers was supported by a new cutting-edge technical conference, the inaugural two-day Keynote Series with Pharmaceutical Technology, Poster Hall and Awards with BioProcess International and INTERPHEX Live with Pharmaceutical Processing. INTERPHEX 2016 was held April 26-28 at the Jacob K. Javits Center in New York City.
“INTERPHEX 2016 was a resounding success for both exhibitors and attendees alike who hailed from 52 countries around the world and 48 states across the U.S.,” said Ed Several, Senior Vice President, INTERPHEX. “This year’s INTERPHEX once again succeeded in bringing together inspired professionals with key industry leaders to share knowledge and best practices, as well as see the latest cutting-edge technologies needed to cost-effectively develop and manufacture quality products.”
INTERPHEX 2016 debuted a new two-day Keynote Series that featured industry experts delivering insights on key themes including drug shortage, continuous manufacturing, overcoming bottlenecks, technology advances in solid dosage, sterile manufacturing challenges, and the contract services market.
During the Keynote Series, Dr. Stephen Spielberg led an engaging presentation titled, “An Interdisciplinary Approach to Address Drug Shortages” that explored alternative, innovative and cost-effective methods to provide needed therapies to patients. "One of the biggest threats to public health in the U.S. is drug shortages and, in order to solve this growing problem, we have to approach manufacturing in a very different way," said Dr. Stephen Spielberg, CEO and President of the Secure Affordable Quality Supply (SAQS) Alliance, a non-profit focused on drug shortages and future of the pharmaceutical manufacturing. "Through a public and private partnership, we can create a financially viable, hybrid manufacturing operation where we can ensure quality, consistent drug production and keep costs down. Technology is a major component to making this happen, and that is why INTERPHEX is such an important event - it's where pharmaceutical science and commercialization merge."
“It was a pleasure being at INTERPHEX and participating. The show and the sessions were a blast. In my amazement, at the session, all the chairs were filled and many were standing in the back and on the sides,” said Robert Dream, Managing Director, HDR Company LLC. “Many attendees stayed afterwards and asked many questions. INTERPHEX has improved on quality and accessibility for attendees on all fronts and I am glad to be a part of it.”
“We see INTERPHEX as a key platform to connect with the market, and gauge the pulse of the industry. Undeniably, continuous processing was the talk of the show, and at Pall Life Sciences, we have developed several technologies designed to enable continuous processing in key downstream unit operations,” said Michael Egholm, PhD, VP & General Manager of Biopharmaceuticals. “It is extremely valuable to hear the input from customers as we continue to develop this industry leading platform, and create new solutions to continuously improve bioprocessing for the industry. Our team looks forward to sharing our advances in continuous bioprocessing in 2017.”
INTERPHEX has transformed into the industry event where more and more manufacturers are launching cutting-edge technologies, products and value-added services for worldwide development and manufacturing operations, including Marchesini Group, MG America, Pall Life Sciences, SKAN, BOSCH, CVC Technologies, Fette Compacting, Watson-Marlow, Entegris, NJM Packaging, PendoTECH, Whitehouse Laboratories, and more.
“We are extremely satisfied with the attendance and quality of our leads,” said Dan Lapierre, Vice President, NJM Packaging. “We met many new customers and reconnected with our current customers. We look forward to next year.”
The following are key highlights from INTERPHEX 2016:
- The second inaugural, three-day INTERPHEX Live enabled industry professionals to gain valuable insights on a variety of topics such as continuous processing, augmented/virtual reality, biosimilars, overcoming facility upgrades and more. Both attendees and exhibitors had the opportunity to view presentations and panels live on the show floor studio, broadcast throughout the show floor and “on-demand” viewing post-show on the INTERPHEX and Pharmaceutical Processing websites.
- Back by popular demand, SKAN US, Inc., a subsidiary of SKAN AG Switzerland and the world’s largest provider of isolator technology, once again held the SKAN Engineering Olympics at its booth. The contest showcased the dexterity and flexibility of its PSI-L Flange Isolator while allowing attendees to compete for prizes.
- DME, a provider of a wide array of engineering solutions, featured the new DME Facility Focus, encompassing feedback and analysis regarding Biopharmaceutical Facility Modernization and Aseptic Manufacturing Technology Trends. “INTERPHEX has become an indispensable vehicle to reach our market and meet with key clients,” said Dave Marks, P.E. and President of DME. “We were extremely pleased to launch the DME Facility Focus educational program at INTERPHEX, which provided an excellent opportunity to showcase DME’s thought leadership and enhanced the overall experience of attendees at the event.”
INTERPHEX 2016 Exhibitor Awards
In conjunction with Pharmaceutical Processing, INTERPHEX announced the winners of its Exhibitor Awards which recognized innovative technologies and/or new strategies and services that have significantly contributed to the industry.
- Best in Show: GE Healthcare Life Sciences
o GE Healthcare Life Sciences was recognized for KUBio™, a prefabricated cGMP-compliant facility and process solution designed for the scalable and cost-efficient production of monoclonal antibodies (mAbs). “INTERPHEX provided us an opportunity to showcase our complete manufacturing solution, KUBio™, and help attendees experience this flexible, turnkey modular facility and understand why it is resonating strongly with our customers,” said Parrish Galliher, Chief Technology Officer, Upstream, GE Healthcare Life Sciences.
- Efficiency Champion: Millipore Sigma
o Millipore Sigma was recognized for Mobius® 1000 L Single-Use Bioreactor, a stirred tank bioreactor that configures software, hardware, and single-use assemblies for use in suspension and adherent cell culture applications. “INTERPHEX is THE trade show for our hardware and single-use business,” said Oliver Klaeffling, Vice President, Head of Upstream & Systems, MilliporeSigma. “This is the year where we’ve launched the most products ever. We have the new 1,000-liter Bioreactor, the new Power MIX, and the revolutionary product in terms of sterile connecting and reconnecting, the Lynx CDR, which is going to change the industry. I’m very happy we won the Efficiency Champion award for our new bioreactor. It’s exactly what the product was designed for-ease of use and increasing manufacturing efficiency for our customers. I’d like to thank our R&D and marketing teams for their hard work on this.”
- Best New Product/Service: Nemera
o Nemera was recognized for Novelia® BFS, a preservative-free multi-dose eyedropper combined with bottlepack® technology. Novelia® works with high viscosity suspensions and solutions of up to 1500 cps and limits the distribution of liquids to one drop at a time. “INTERPHEX was a great opportunity for us to have high-quality discussions and meet several customers and prospects,” said Patrice Lewko, Vice-President Marketing and Innovation, Nemera. “We are proud to have Novelia® awarded as ‘Best New Product’ at INTERPHEX 2016. With Novelia®, Nemera is proud to bring a safe and cost-effective solution for eliminating preservatives from eye drops. This is improving treatment compliance and patients' safety and comfort. By combining Novelia® with the Bottlepack® blow-fill-seal technology by Rommelag, we make it even safer, more convenient and easier to implement.”
- Other INTERPHEX 2016 award winners include:
o Biotech Innovation Award: Bausch + Stroebel for VarioSys®, a flexible processing line based on the lock-and-key principle.
o Best Technological Innovation: Videojet Technologies for its Videojet® 7510 50-Watt Fiber Laser Marker, a laser marking system with high contrast marking on robust plastic packaging, metal containers, as well as other industrial products.
o Editor’s Choice: Catalent Pharma Solutions for its OptiForm® Solution Suite, a detailed molecule assessment with high throughput screening and parallel assessment of formulation technologies.
Save the date! INTERPHEX 2017 will be held from March 21-23, 2017 at the Javits Center in New York City.
About INTERPHEX
INTERPHEX (International Pharmaceutical Expo), is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by the Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies, and Knowledge, the show focuses on the entire product development life cycle, offering solutions to cost effectively develop and manufacture products. Held in New York, it brings over 10,000 global industry professionals together with 600+ suppliers through a unique combination of our no cost technical conference, exhibits, demonstrations, workshops, partnering opportunities, and networking events. INTERPHEX offers annual national and international industry events and educational opportunities around the world. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. IPX Blog continues the learning beyond the show floor. For more information, visit http://www.INTERPHEX.com.